Stop obsessing over hitting exactly 10 reps—recent findings reveal that training to failure is the ultimate equalizer for strength and hypertrophy.

From rare cancers caught early to dementia foretold decades in advance, newborn genomic testing raises an unsettling question ...

FDA priority review seeks marstacimab label expansion to ≥6 years with inhibitors and ages 6–11 without inhibitors, addressing populations with limited efficacy from factor replacement and high unmet ...

Sustained interest in small molecules, bispecific antibodies, and genomics got the ball rolling in the biotech deals arena in ...

The result is a screening assessment that aims to identify cancer at a much earlier stage than many existing methods.

Eli Lilly’s Zepbound is still viewed as the leading weight-loss shot, according to a ...

Discover how Electroencephalography (EEG) records brain activity to diagnose epilepsy, strokes, and sleep disorders. Learn ...

Debated is the genesis of the first direct-to-consumer (DTC) drug concept in the U.S. Going back to at least 2011, Pfizer’s “unorthodox” ...

Results from a recently published randomized, double-blind, placebo-controlled clinical trial show that supplementation with Brightseed® BioMetaControl, containing the naturally occurring bioactive ...

Low back pain (LBP) is a crucial risk factor for future health decline, affecting quality of life of individuals. Now, researchers have discovered ...

A new survey highlights just how few people are aware of CKM syndrome. But most American adults have at least some risk of ...